175 related articles for article (PubMed ID: 15529292)
1. AT1 receptor agonistic antibodies, hypertension, and preeclampsia.
Dechend R; Müller DN; Wallukat G; Homuth V; Krause M; Dudenhausen J; Luft FC
Semin Nephrol; 2004 Nov; 24(6):571-9. PubMed ID: 15529292
[TBL] [Abstract][Full Text] [Related]
2. Activating auto-antibodies against the AT1 receptor in preeclampsia.
Dechend R; Müller DN; Wallukat G; Homuth V; Krause M; Dudenhausen J; Luft FC
Autoimmun Rev; 2005 Jan; 4(1):61-5. PubMed ID: 15652781
[TBL] [Abstract][Full Text] [Related]
3. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia.
Dechend R; Homuth V; Wallukat G; Müller DN; Krause M; Dudenhausen J; Haller H; Luft FC
J Soc Gynecol Investig; 2006 Feb; 13(2):79-86. PubMed ID: 16443499
[TBL] [Abstract][Full Text] [Related]
4. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells.
Xia Y; Wen H; Bobst S; Day MC; Kellems RE
J Soc Gynecol Investig; 2003 Feb; 10(2):82-93. PubMed ID: 12593997
[TBL] [Abstract][Full Text] [Related]
5. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
LaMarca B; Parrish MR; Wallace K
Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
[TBL] [Abstract][Full Text] [Related]
6. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.
Dechend R; Viedt C; Müller DN; Ugele B; Brandes RP; Wallukat G; Park JK; Janke J; Barta P; Theuer J; Fiebeler A; Homuth V; Dietz R; Haller H; Kreuzer J; Luft FC
Circulation; 2003 Apr; 107(12):1632-9. PubMed ID: 12668498
[TBL] [Abstract][Full Text] [Related]
7. The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia.
Campbell N; LaMarca B; Cunningham MW
Curr Pharm Biotechnol; 2018; 19(10):781-785. PubMed ID: 30255752
[TBL] [Abstract][Full Text] [Related]
8. Auto-antibodies against the angiotensin II type I receptor in women with uteroplacental acute atherosis and preeclampsia at delivery and several years postpartum.
Rieber-Mohn AB; Sugulle M; Wallukat G; Alnæs-Katjavivi P; Leite Størvold G; Bolstad N; Redman CW; Dechend R; Staff AC
J Reprod Immunol; 2018 Aug; 128():23-29. PubMed ID: 29843114
[TBL] [Abstract][Full Text] [Related]
9. Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation.
Thway TM; Shlykov SG; Day MC; Sanborn BM; Gilstrap LC; Xia Y; Kellems RE
Circulation; 2004 Sep; 110(12):1612-9. PubMed ID: 15381659
[TBL] [Abstract][Full Text] [Related]
10. Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia.
Liu F; Wang Y; Wang X; Zheng Y; Jin Z; Zhi J
Sci Rep; 2016 Jul; 6():29036. PubMed ID: 27381670
[TBL] [Abstract][Full Text] [Related]
11. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.
Wallukat G; Neichel D; Nissen E; Homuth V; Luft FC
Can J Physiol Pharmacol; 2003 Feb; 81(2):79-83. PubMed ID: 12710518
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.
Xia Y; Kellems RE
Circ Res; 2013 Jun; 113(1):78-87. PubMed ID: 23788505
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia.
Yang J; Li L; Shang JY; Cai L; Song L; Zhang SL; Li H; Li X; Lau WB; Ma XL; Liu HR
J Hypertens; 2015 May; 33(5):1046-56. PubMed ID: 25693057
[TBL] [Abstract][Full Text] [Related]
15. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.
Wallukat G; Homuth V; Fischer T; Lindschau C; Horstkamp B; Jüpner A; Baur E; Nissen E; Vetter K; Neichel D; Dudenhausen JW; Haller H; Luft FC
J Clin Invest; 1999 Apr; 103(7):945-52. PubMed ID: 10194466
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II Type I Receptor Agonistic Autoantibody Induces Podocyte Injury via Activation of the TRPC6- Calcium/Calcineurin Pathway in Pre-Eclampsia.
Yu Y; Zhang L; Xu G; Wu Z; Li Q; Gu Y; Niu J
Kidney Blood Press Res; 2018; 43(5):1666-1676. PubMed ID: 30380548
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.
Herse F; LaMarca B
Am J Reprod Immunol; 2013 Apr; 69(4):413-8. PubMed ID: 23279165
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.
LaMarca B; Parrish M; Ray LF; Murphy SR; Roberts L; Glover P; Wallukat G; Wenzel K; Cockrell K; Martin JN; Ryan MJ; Dechend R
Hypertension; 2009 Oct; 54(4):905-9. PubMed ID: 19704104
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
Brewer J; Liu R; Lu Y; Scott J; Wallace K; Wallukat G; Moseley J; Herse F; Dechend R; Martin JN; Lamarca B
Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A
Liu H; Cheng F; Xu Q; Huang W; Wang S; Sun R; Ye D; Zhang D
Cell Death Dis; 2020 Jan; 11(1):78. PubMed ID: 32001671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
